| 0 |
PH BODY FLUID INCREASED |
6 |
0.2609 |
| 1 |
GASTROINTESTINAL SUBMUCOSAL TUMOUR |
6 |
0.1304 |
| 2 |
TRANSFERRIN INCREASED |
7 |
0.1250 |
| 3 |
CARDIAC VALVE SCLEROSIS |
6 |
0.0833 |
| 4 |
PRODUCT DELIVERY MECHANISM ISSUE |
317 |
0.0589 |
| 5 |
PROLONGED EXPIRATION |
13 |
0.0496 |
| 6 |
COSTOVERTEBRAL ANGLE TENDERNESS |
6 |
0.0366 |
| 7 |
HYDROCHOLECYSTIS |
6 |
0.0324 |
| 8 |
INFUSION SITE DISCHARGE |
47 |
0.0268 |
| 9 |
INFUSION SITE THROMBOSIS |
7 |
0.0261 |
| 10 |
PERITONEAL ADHESIONS |
6 |
0.0236 |
| 11 |
PRECANCEROUS CONDITION |
14 |
0.0209 |
| 12 |
OXYGEN SATURATION INCREASED |
7 |
0.0206 |
| 13 |
SPUTUM PURULENT |
13 |
0.0198 |
| 14 |
INFUSION SITE BRUISING |
38 |
0.0176 |
| 15 |
INFUSION SITE MASS |
18 |
0.0166 |
| 16 |
TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME |
7 |
0.0164 |
| 17 |
PATIENT DISSATISFACTION WITH DEVICE |
4 |
0.0159 |
| 18 |
CEREBRAL ARTERIOSCLEROSIS |
6 |
0.0155 |
| 19 |
INFUSION SITE HAEMORRHAGE |
47 |
0.0143 |
| 20 |
INFUSION SITE SCAR |
6 |
0.0135 |
| 21 |
DEATH OF RELATIVE |
5 |
0.0123 |
| 22 |
PO2 INCREASED |
6 |
0.0118 |
| 23 |
PRODUCT LEAKAGE |
64 |
0.0114 |
| 24 |
REFLUX LARYNGITIS |
5 |
0.0113 |
| 25 |
BLADDER HYPERTROPHY |
5 |
0.0113 |
| 26 |
LEFT ATRIAL ENLARGEMENT |
6 |
0.0111 |
| 27 |
PERIORBITAL PAIN |
9 |
0.0106 |
| 28 |
INFUSION SITE DISCOMFORT |
11 |
0.0106 |
| 29 |
DEVICE INFUSION ISSUE |
25 |
0.0101 |
| 30 |
INFUSION SITE SWELLING |
63 |
0.0100 |
| 31 |
MULTIPLE ALLERGIES |
78 |
0.0099 |
| 32 |
SCAR PAIN |
4 |
0.0099 |
| 33 |
INFUSION SITE PRURITUS |
30 |
0.0095 |
| 34 |
TREATMENT FAILURE |
782 |
0.0094 |
| 35 |
INFUSION SITE NODULE |
9 |
0.0094 |
| 36 |
ALLERGIC SINUSITIS |
8 |
0.0093 |
| 37 |
INFUSION SITE URTICARIA |
6 |
0.0090 |
| 38 |
INFUSION SITE ERYTHEMA |
74 |
0.0088 |
| 39 |
ALLERGY TO PLANTS |
4 |
0.0088 |
| 40 |
SEASONAL ALLERGY |
122 |
0.0086 |
| 41 |
PRODUCT AFTER TASTE |
8 |
0.0084 |
| 42 |
INFUSION SITE WARMTH |
10 |
0.0082 |
| 43 |
DEVICE LOOSENING |
7 |
0.0081 |
| 44 |
INFUSION SITE RASH |
11 |
0.0080 |
| 45 |
INFUSION SITE DISCOLOURATION |
7 |
0.0080 |
| 46 |
CHORIORETINOPATHY |
11 |
0.0077 |
| 47 |
NASAL CRUSTING |
5 |
0.0077 |
| 48 |
INFUSION SITE VESICLES |
4 |
0.0076 |
| 49 |
SINUSITIS BACTERIAL |
8 |
0.0076 |
| 50 |
INFUSION SITE PAIN |
97 |
0.0075 |
| 51 |
PRODUCT CONTAINER SEAL ISSUE |
13 |
0.0075 |
| 52 |
INFUSION SITE IRRITATION |
9 |
0.0070 |
| 53 |
DEVICE MAINTENANCE ISSUE |
4 |
0.0068 |
| 54 |
INFUSION SITE INDURATION |
10 |
0.0067 |
| 55 |
CHRONIC SINUSITIS |
25 |
0.0067 |
| 56 |
ALLERGIC COUGH |
5 |
0.0065 |
| 57 |
ABULIA |
6 |
0.0065 |
| 58 |
PCO2 DECREASED |
6 |
0.0062 |
| 59 |
BLOOD IMMUNOGLOBULIN A DECREASED |
4 |
0.0061 |
| 60 |
HEAT ILLNESS |
4 |
0.0059 |
| 61 |
EYELID PAIN |
12 |
0.0059 |
| 62 |
PNEUMONIA INFLUENZAL |
7 |
0.0059 |
| 63 |
HELICOBACTER GASTRITIS |
7 |
0.0056 |
| 64 |
FACIAL DISCOMFORT |
4 |
0.0056 |
| 65 |
PRODUCT DESIGN ISSUE |
4 |
0.0056 |
| 66 |
NASAL PRURITUS |
7 |
0.0056 |
| 67 |
SINUS OPERATION |
12 |
0.0050 |
| 68 |
ANTEROGRADE AMNESIA |
3 |
0.0050 |
| 69 |
MAST CELL ACTIVATION SYNDROME |
7 |
0.0050 |
| 70 |
POST-ACUTE COVID-19 SYNDROME |
6 |
0.0048 |
| 71 |
RHINALGIA |
13 |
0.0047 |
| 72 |
ENDOCRINE OPHTHALMOPATHY |
4 |
0.0046 |
| 73 |
SUPERFICIAL INJURY OF EYE |
5 |
0.0046 |
| 74 |
NASAL DISCOMFORT |
36 |
0.0045 |
| 75 |
OBSTRUCTION |
18 |
0.0045 |
| 76 |
PLEUROTHOTONUS |
4 |
0.0044 |
| 77 |
GASTROINTESTINAL BACTERIAL INFECTION |
5 |
0.0044 |
| 78 |
UPPER-AIRWAY COUGH SYNDROME |
36 |
0.0044 |
| 79 |
ADMINISTRATION SITE PAIN |
5 |
0.0043 |
| 80 |
INSURANCE ISSUE |
66 |
0.0043 |
| 81 |
SPINAL CORD DISORDER |
7 |
0.0043 |
| 82 |
INCORRECT DRUG ADMINISTRATION RATE |
18 |
0.0042 |
| 83 |
OXYGEN CONSUMPTION INCREASED |
10 |
0.0042 |
| 84 |
PROSTATE INFECTION |
4 |
0.0042 |
| 85 |
SINUS DISORDER |
81 |
0.0041 |
| 86 |
PRODUCT ODOUR ABNORMAL |
42 |
0.0040 |
| 87 |
ADHESION |
6 |
0.0040 |
| 88 |
HORDEOLUM |
17 |
0.0039 |
| 89 |
OXYGEN SATURATION ABNORMAL |
11 |
0.0039 |
| 90 |
INFUSION SITE INFECTION |
9 |
0.0039 |
| 91 |
BONE DEMINERALISATION |
4 |
0.0038 |
| 92 |
HYPERTENSIVE HEART DISEASE |
7 |
0.0037 |
| 93 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
5 |
0.0037 |
| 94 |
MIDDLE EAR EFFUSION |
8 |
0.0036 |
| 95 |
DERMATITIS CONTACT |
40 |
0.0035 |
| 96 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
5 |
0.0034 |
| 97 |
PARANASAL SINUS HYPERSECRETION |
13 |
0.0034 |
| 98 |
DEVICE DEFECTIVE |
58 |
0.0033 |
| 99 |
HYPOSMIA |
5 |
0.0033 |
| 100 |
SINUS HEADACHE |
19 |
0.0032 |
| 101 |
PARANASAL SINUS DISCOMFORT |
12 |
0.0032 |
| 102 |
EAR INFECTION |
84 |
0.0032 |
| 103 |
SUBCUTANEOUS HAEMATOMA |
4 |
0.0031 |
| 104 |
SINUSITIS |
315 |
0.0031 |
| 105 |
SPUTUM DISCOLOURED |
29 |
0.0031 |
| 106 |
SHOULDER FRACTURE |
5 |
0.0031 |
| 107 |
INFUSION SITE EXTRAVASATION |
19 |
0.0030 |
| 108 |
NASAL POLYPS |
15 |
0.0030 |
| 109 |
PRODUCT DISTRIBUTION ISSUE |
28 |
0.0030 |
| 110 |
INFUSION SITE REACTION |
9 |
0.0030 |
| 111 |
LIP EXFOLIATION |
4 |
0.0030 |
| 112 |
RESPIRATORY TRACT INFECTION |
76 |
0.0029 |
| 113 |
IMMUNOGLOBULINS DECREASED |
4 |
0.0029 |
| 114 |
ACUTE SINUSITIS |
5 |
0.0029 |
| 115 |
CYSTIC FIBROSIS |
16 |
0.0029 |
| 116 |
VERTIGO POSITIONAL |
5 |
0.0029 |
| 117 |
EAR SWELLING |
6 |
0.0028 |
| 118 |
BLOOD IMMUNOGLOBULIN G DECREASED |
7 |
0.0028 |
| 119 |
ALLERGY TO ANIMAL |
3 |
0.0028 |
| 120 |
NOROVIRUS INFECTION |
4 |
0.0028 |
| 121 |
DEVICE ALARM ISSUE |
5 |
0.0028 |
| 122 |
FOOD ALLERGY |
21 |
0.0027 |
| 123 |
CONJUNCTIVITIS ALLERGIC |
4 |
0.0027 |
| 124 |
PRODUCT CONTAINER ISSUE |
23 |
0.0027 |
| 125 |
ATYPICAL PNEUMONIA |
8 |
0.0027 |
| 126 |
UPPER RESPIRATORY TRACT INFECTION |
122 |
0.0026 |
| 127 |
PNEUMONIA PSEUDOMONAL |
4 |
0.0026 |
| 128 |
SINUS CONGESTION |
35 |
0.0026 |
| 129 |
PHARYNGITIS STREPTOCOCCAL |
28 |
0.0026 |
| 130 |
SNEEZING |
58 |
0.0026 |
| 131 |
SINUS PAIN |
6 |
0.0026 |
| 132 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
6 |
0.0025 |
| 133 |
FOREIGN BODY SENSATION IN EYES |
16 |
0.0025 |
| 134 |
HYPERPHAGIA |
10 |
0.0025 |
| 135 |
RESPIRATORY TRACT CONGESTION |
39 |
0.0025 |
| 136 |
GASTROINTESTINAL INFECTION |
22 |
0.0025 |
| 137 |
PRODUCT TASTE ABNORMAL |
33 |
0.0024 |
| 138 |
DEVICE MALFUNCTION |
170 |
0.0024 |
| 139 |
DYSPNOEA AT REST |
7 |
0.0024 |
| 140 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
21 |
0.0024 |
| 141 |
VEIN RUPTURE |
4 |
0.0024 |
| 142 |
PRODUCTIVE COUGH |
114 |
0.0024 |
| 143 |
DEVICE CONNECTION ISSUE |
5 |
0.0024 |
| 144 |
SLEEP DEFICIT |
5 |
0.0024 |
| 145 |
PHYSICAL DECONDITIONING |
6 |
0.0023 |
| 146 |
THERAPEUTIC PRODUCT INEFFECTIVE |
9 |
0.0023 |
| 147 |
HIATUS HERNIA |
30 |
0.0023 |
| 148 |
TREATMENT DELAYED |
4 |
0.0023 |
| 149 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
6 |
0.0023 |
| 150 |
PRODUCT DOSE OMISSION ISSUE |
672 |
0.0023 |
| 151 |
DIASTOLIC DYSFUNCTION |
7 |
0.0023 |
| 152 |
ACROCHORDON |
3 |
0.0023 |
| 153 |
ANIMAL BITE |
6 |
0.0022 |
| 154 |
RHINITIS ALLERGIC |
10 |
0.0022 |
| 155 |
DEVICE BREAKAGE |
91 |
0.0022 |
| 156 |
STUPOR |
7 |
0.0022 |
| 157 |
BODY TEMPERATURE ABNORMAL |
4 |
0.0022 |
| 158 |
ARTHROPOD BITE |
16 |
0.0022 |
| 159 |
NASAL CONGESTION |
125 |
0.0021 |
| 160 |
EYE PAIN |
120 |
0.0021 |
| 161 |
EYE INFECTION |
24 |
0.0021 |
| 162 |
ASTHMA |
240 |
0.0021 |
| 163 |
SUSPECTED COVID-19 |
7 |
0.0021 |
| 164 |
NARCOLEPSY |
4 |
0.0021 |
| 165 |
SNORING |
8 |
0.0021 |
| 166 |
SKIN ABRASION |
10 |
0.0021 |
| 167 |
GASTRIC INFECTION |
8 |
0.0021 |
| 168 |
HYPERTONIC BLADDER |
6 |
0.0021 |
| 169 |
PATIENT DISSATISFACTION WITH TREATMENT |
4 |
0.0021 |
| 170 |
NO ADVERSE EVENT |
374 |
0.0021 |
| 171 |
GASTROENTERITIS VIRAL |
37 |
0.0020 |
| 172 |
NASAL SEPTUM DEVIATION |
4 |
0.0020 |
| 173 |
HYPOGEUSIA |
4 |
0.0020 |
| 174 |
REGURGITATION |
7 |
0.0020 |
| 175 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
34 |
0.0020 |
| 176 |
EAR PRURITUS |
7 |
0.0020 |
| 177 |
BLEPHARITIS |
8 |
0.0020 |
| 178 |
PAROSMIA |
15 |
0.0020 |
| 179 |
VASODILATATION |
5 |
0.0020 |
| 180 |
VASCULAR DEVICE INFECTION |
9 |
0.0020 |
| 181 |
ENURESIS |
8 |
0.0020 |
| 182 |
SKIN WEEPING |
7 |
0.0020 |
| 183 |
DUODENITIS |
6 |
0.0020 |
| 184 |
PERIORBITAL SWELLING |
11 |
0.0019 |
| 185 |
THROAT IRRITATION |
85 |
0.0019 |
| 186 |
EMPHYSEMA |
19 |
0.0019 |
| 187 |
OROPHARYNGEAL DISCOMFORT |
17 |
0.0019 |
| 188 |
CATHETER SITE ERYTHEMA |
4 |
0.0019 |
| 189 |
THROAT CLEARING |
7 |
0.0019 |
| 190 |
APHONIA |
26 |
0.0019 |
| 191 |
INJECTION SITE DISCHARGE |
10 |
0.0019 |
| 192 |
PRODUCT USE COMPLAINT |
29 |
0.0018 |
| 193 |
SKIN LACERATION |
20 |
0.0018 |
| 194 |
ARTHROPOD STING |
3 |
0.0018 |
| 195 |
RHINOVIRUS INFECTION |
7 |
0.0018 |
| 196 |
SKIN INFECTION |
20 |
0.0018 |
| 197 |
DRUG TOLERANCE DECREASED |
5 |
0.0018 |
| 198 |
HEREDITARY ANGIOEDEMA |
19 |
0.0018 |
| 199 |
BRONCHITIS |
130 |
0.0018 |
| 200 |
DIZZINESS POSTURAL |
17 |
0.0018 |
| 201 |
SWELLING OF EYELID |
11 |
0.0018 |
| 202 |
EAR DISORDER |
8 |
0.0017 |
| 203 |
ORAL PRURITUS |
4 |
0.0017 |
| 204 |
RHINITIS |
14 |
0.0017 |
| 205 |
FUNGAL SKIN INFECTION |
7 |
0.0017 |
| 206 |
EYE DISCHARGE |
18 |
0.0017 |
| 207 |
BRAIN FOG |
27 |
0.0017 |
| 208 |
ROSACEA |
8 |
0.0017 |
| 209 |
VIRAL INFECTION |
57 |
0.0017 |
| 210 |
FOOD POISONING |
9 |
0.0017 |
| 211 |
ERYTHEMA OF EYELID |
9 |
0.0017 |
| 212 |
EXPOSURE VIA SKIN CONTACT |
43 |
0.0017 |
| 213 |
RHINORRHOEA |
107 |
0.0017 |
| 214 |
BLOOD IMMUNOGLOBULIN E INCREASED |
4 |
0.0017 |
| 215 |
EAR PAIN |
32 |
0.0016 |
| 216 |
POOR VENOUS ACCESS |
17 |
0.0016 |
| 217 |
BREATH ODOUR |
4 |
0.0016 |
| 218 |
BRONCHITIS CHRONIC |
4 |
0.0016 |
| 219 |
MASTICATION DISORDER |
5 |
0.0016 |
| 220 |
TENSION HEADACHE |
7 |
0.0016 |
| 221 |
MENISCUS INJURY |
10 |
0.0016 |
| 222 |
WEIGHT FLUCTUATION |
17 |
0.0016 |
| 223 |
FOOT OPERATION |
8 |
0.0016 |
| 224 |
ILLNESS |
166 |
0.0016 |
| 225 |
BLADDER SPASM |
3 |
0.0016 |
| 226 |
CANDIDA INFECTION |
27 |
0.0016 |
| 227 |
SECRETION DISCHARGE |
20 |
0.0016 |
| 228 |
RESPIRATION ABNORMAL |
11 |
0.0016 |
| 229 |
DYSPNOEA EXERTIONAL |
60 |
0.0016 |
| 230 |
DECREASED ACTIVITY |
17 |
0.0016 |
| 231 |
ABDOMINAL INFECTION |
4 |
0.0016 |
| 232 |
ADRENAL DISORDER |
3 |
0.0016 |
| 233 |
COVID-19 |
274 |
0.0016 |
| 234 |
DRUG TITRATION ERROR |
4 |
0.0015 |
| 235 |
LIPOMA |
4 |
0.0015 |
| 236 |
PRODUCT ADMINISTRATION INTERRUPTED |
12 |
0.0015 |
| 237 |
ORAL CANDIDIASIS |
20 |
0.0015 |
| 238 |
IDIOPATHIC PULMONARY FIBROSIS |
6 |
0.0015 |
| 239 |
OCULAR DISCOMFORT |
17 |
0.0015 |
| 240 |
MIDDLE INSOMNIA |
28 |
0.0015 |
| 241 |
PLANTAR FASCIITIS |
5 |
0.0015 |
| 242 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
4 |
0.0015 |
| 243 |
INJECTION SITE VESICLES |
9 |
0.0015 |
| 244 |
KIDNEY INFECTION |
29 |
0.0015 |
| 245 |
PULMONARY MASS |
22 |
0.0015 |
| 246 |
ABDOMINAL RIGIDITY |
4 |
0.0015 |
| 247 |
TRIGGER FINGER |
6 |
0.0015 |
| 248 |
DRY EYE |
73 |
0.0015 |
| 249 |
OXYGEN SATURATION DECREASED |
81 |
0.0014 |
| 250 |
TOOTH INFECTION |
19 |
0.0014 |
| 251 |
EOSINOPHIL COUNT INCREASED |
12 |
0.0014 |
| 252 |
COVID-19 PNEUMONIA |
17 |
0.0014 |
| 253 |
NASAL DRYNESS |
9 |
0.0014 |
| 254 |
PHOTOPHOBIA |
27 |
0.0014 |
| 255 |
ELECTRIC SHOCK SENSATION |
4 |
0.0014 |
| 256 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
6 |
0.0014 |
| 257 |
LIGAMENT SPRAIN |
14 |
0.0014 |
| 258 |
INCREASED TENDENCY TO BRUISE |
13 |
0.0014 |
| 259 |
PRODUCT DOSE OMISSION IN ERROR |
40 |
0.0014 |
| 260 |
GASTROINTESTINAL SOUNDS ABNORMAL |
7 |
0.0014 |
| 261 |
AORTIC VALVE INCOMPETENCE |
6 |
0.0014 |
| 262 |
PRODUCT DISPENSING ISSUE |
6 |
0.0014 |
| 263 |
COUGH |
392 |
0.0014 |
| 264 |
SKIN SWELLING |
12 |
0.0014 |
| 265 |
CHAPPED LIPS |
6 |
0.0014 |
| 266 |
SPONDYLITIS |
5 |
0.0014 |
| 267 |
FAECES SOFT |
10 |
0.0014 |
| 268 |
PULMONARY FUNCTION TEST DECREASED |
6 |
0.0014 |
| 269 |
DEVICE POWER SOURCE ISSUE |
4 |
0.0014 |
| 270 |
INITIAL INSOMNIA |
14 |
0.0014 |
| 271 |
EAR DISCOMFORT |
14 |
0.0014 |
| 272 |
HYPERACUSIS |
5 |
0.0013 |
| 273 |
BACTERIAL INFECTION |
25 |
0.0013 |
| 274 |
EYE PRURITUS |
45 |
0.0013 |
| 275 |
MENINGITIS ASEPTIC |
6 |
0.0013 |
| 276 |
POSTOPERATIVE WOUND INFECTION |
9 |
0.0013 |
| 277 |
PHARYNGEAL SWELLING |
13 |
0.0013 |
| 278 |
IMPAIRED QUALITY OF LIFE |
19 |
0.0013 |
| 279 |
CRANIOCEREBRAL INJURY |
4 |
0.0013 |
| 280 |
HAEMOGLOBIN INCREASED |
6 |
0.0013 |
| 281 |
LUMBAR VERTEBRAL FRACTURE |
6 |
0.0013 |
| 282 |
BODY HEIGHT DECREASED |
14 |
0.0013 |
| 283 |
CONJUNCTIVAL HAEMORRHAGE |
5 |
0.0013 |
| 284 |
BUNDLE BRANCH BLOCK RIGHT |
6 |
0.0013 |
| 285 |
WHEEZING |
77 |
0.0013 |
| 286 |
OROPHARYNGEAL PAIN |
120 |
0.0013 |
| 287 |
GASTRITIS EROSIVE |
6 |
0.0013 |
| 288 |
ORAL INFECTION |
5 |
0.0013 |
| 289 |
EYE IRRITATION |
73 |
0.0013 |
| 290 |
FEAR OF INJECTION |
9 |
0.0013 |
| 291 |
GESTATIONAL DIABETES |
6 |
0.0013 |
| 292 |
STREPTOCOCCAL INFECTION |
7 |
0.0013 |
| 293 |
LACRIMATION INCREASED |
38 |
0.0013 |
| 294 |
PNEUMONIA VIRAL |
4 |
0.0013 |
| 295 |
DEVICE LEAKAGE |
54 |
0.0012 |
| 296 |
ANOSMIA |
18 |
0.0012 |
| 297 |
INJECTION SITE INFECTION |
4 |
0.0012 |
| 298 |
LIMB INJURY |
33 |
0.0012 |
| 299 |
LISTLESS |
4 |
0.0012 |
| 300 |
CYST |
15 |
0.0012 |
| 301 |
ECZEMA |
63 |
0.0012 |
| 302 |
PNEUMONIA BACTERIAL |
11 |
0.0012 |
| 303 |
CEREBRAL HAEMATOMA |
4 |
0.0012 |
| 304 |
ORAL HERPES |
23 |
0.0012 |
| 305 |
ARTERIOSCLEROSIS |
11 |
0.0012 |
| 306 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
20 |
0.0012 |
| 307 |
PSEUDOMONAS INFECTION |
10 |
0.0012 |
| 308 |
MUSCULOSKELETAL DISCOMFORT |
20 |
0.0012 |
| 309 |
PRODUCT PACKAGING ISSUE |
11 |
0.0012 |
| 310 |
BURSITIS |
14 |
0.0012 |
| 311 |
EPISTAXIS |
86 |
0.0011 |
| 312 |
DEVICE ISSUE |
103 |
0.0011 |
| 313 |
CONJUNCTIVITIS |
21 |
0.0011 |
| 314 |
PHARYNGITIS |
14 |
0.0011 |
| 315 |
SKIN FISSURES |
22 |
0.0011 |
| 316 |
PRE-EXISTING CONDITION IMPROVED |
7 |
0.0011 |
| 317 |
GINGIVITIS |
6 |
0.0011 |
| 318 |
FOOT FRACTURE |
21 |
0.0011 |
| 319 |
IMPAIRED GASTRIC EMPTYING |
15 |
0.0011 |
| 320 |
OCULAR HYPERAEMIA |
52 |
0.0011 |
| 321 |
BLOOD IRON DECREASED |
13 |
0.0011 |
| 322 |
ASTHENOPIA |
6 |
0.0011 |
| 323 |
DEAFNESS UNILATERAL |
6 |
0.0011 |
| 324 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
196 |
0.0011 |
| 325 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
10 |
0.0011 |
| 326 |
TASTE DISORDER |
22 |
0.0011 |
| 327 |
NERVE COMPRESSION |
10 |
0.0011 |
| 328 |
INTERVERTEBRAL DISC DEGENERATION |
10 |
0.0011 |
| 329 |
FUNGAL INFECTION |
36 |
0.0011 |
| 330 |
ARTHRITIS INFECTIVE |
5 |
0.0011 |
| 331 |
HEAD DISCOMFORT |
19 |
0.0011 |
| 332 |
TENDERNESS |
11 |
0.0011 |
| 333 |
SLEEP APNOEA SYNDROME |
20 |
0.0010 |
| 334 |
INJECTION SITE DISCOMFORT |
11 |
0.0010 |
| 335 |
INFECTION |
150 |
0.0010 |
| 336 |
RESPIRATORY DISORDER |
31 |
0.0010 |
| 337 |
FAECES HARD |
4 |
0.0010 |
| 338 |
DYSPHONIA |
60 |
0.0010 |
| 339 |
INFLUENZA |
114 |
0.0010 |
| 340 |
MIGRAINE |
97 |
0.0010 |
| 341 |
BREATH SOUNDS ABNORMAL |
5 |
0.0010 |
| 342 |
DYSGEUSIA |
75 |
0.0010 |
| 343 |
FACIAL PAIN |
9 |
0.0010 |
| 344 |
INTERVERTEBRAL DISC PROTRUSION |
22 |
0.0010 |
| 345 |
BLOOD PRESSURE ABNORMAL |
20 |
0.0010 |
| 346 |
GINGIVAL PAIN |
8 |
0.0010 |
| 347 |
CYSTITIS |
32 |
0.0010 |
| 348 |
SALIVARY HYPERSECRETION |
10 |
0.0010 |
| 349 |
TRIGEMINAL NEURALGIA |
4 |
0.0010 |
| 350 |
EYE SWELLING |
37 |
0.0010 |
| 351 |
THERMAL BURN |
7 |
0.0010 |
| 352 |
POST PROCEDURAL INFECTION |
8 |
0.0010 |
| 353 |
CHEST DISCOMFORT |
100 |
0.0010 |
| 354 |
SPINAL STENOSIS |
4 |
0.0010 |
| 355 |
BLOOD POTASSIUM DECREASED |
29 |
0.0010 |
| 356 |
THYROID FUNCTION TEST ABNORMAL |
4 |
0.0010 |
| 357 |
INJECTION SITE DISCOLOURATION |
12 |
0.0010 |
| 358 |
BLOOD SODIUM DECREASED |
18 |
0.0010 |
| 359 |
SPINAL DISORDER |
9 |
0.0009 |
| 360 |
NASOPHARYNGITIS |
175 |
0.0009 |
| 361 |
DRUG EFFECT LESS THAN EXPECTED |
14 |
0.0009 |
| 362 |
SKIN HAEMORRHAGE |
14 |
0.0009 |
| 363 |
TONGUE DISCOMFORT |
4 |
0.0009 |
| 364 |
SCIATICA |
15 |
0.0009 |
| 365 |
ABSCESS LIMB |
4 |
0.0009 |
| 366 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
45 |
0.0009 |
| 367 |
SHOULDER OPERATION |
4 |
0.0009 |
| 368 |
THERAPEUTIC RESPONSE SHORTENED |
31 |
0.0009 |
| 369 |
URINARY TRACT INFECTION |
158 |
0.0009 |
| 370 |
BEHAVIOUR DISORDER |
5 |
0.0009 |
| 371 |
HERPES SIMPLEX |
6 |
0.0009 |
| 372 |
DEVICE PHYSICAL PROPERTY ISSUE |
7 |
0.0009 |
| 373 |
JAW DISORDER |
5 |
0.0009 |
| 374 |
THYROID DISORDER |
14 |
0.0009 |
| 375 |
CHOKING SENSATION |
5 |
0.0009 |
| 376 |
INABILITY TO AFFORD MEDICATION |
9 |
0.0009 |
| 377 |
GINGIVAL SWELLING |
4 |
0.0009 |
| 378 |
CATHETERISATION CARDIAC |
4 |
0.0009 |
| 379 |
WHEELCHAIR USER |
4 |
0.0009 |
| 380 |
ANXIETY DISORDER |
3 |
0.0009 |
| 381 |
GOUT |
16 |
0.0009 |
| 382 |
THROAT TIGHTNESS |
24 |
0.0009 |
| 383 |
DRY THROAT |
9 |
0.0009 |
| 384 |
CONTUSION |
85 |
0.0009 |
| 385 |
SLUGGISHNESS |
9 |
0.0009 |
| 386 |
DEVICE DELIVERY SYSTEM ISSUE |
24 |
0.0009 |
| 387 |
INFUSION RELATED REACTION |
58 |
0.0009 |
| 388 |
LOCALISED INFECTION |
21 |
0.0009 |
| 389 |
RENAL FUNCTION TEST ABNORMAL |
4 |
0.0009 |
| 390 |
DEVICE FAILURE |
13 |
0.0009 |
| 391 |
INCONTINENCE |
9 |
0.0009 |
| 392 |
SKIN TIGHTNESS |
4 |
0.0008 |
| 393 |
INJECTION SITE SWELLING |
65 |
0.0008 |
| 394 |
RETCHING |
18 |
0.0008 |
| 395 |
SARCOIDOSIS |
4 |
0.0008 |
| 396 |
AGEUSIA |
21 |
0.0008 |
| 397 |
CHOLECYSTITIS |
10 |
0.0008 |
| 398 |
SARS-COV-2 TEST POSITIVE |
11 |
0.0008 |
| 399 |
HYPERSENSITIVITY |
153 |
0.0008 |
| 400 |
TENSION |
5 |
0.0008 |
| 401 |
AUTOIMMUNE DISORDER |
8 |
0.0008 |
| 402 |
PRODUCT USE IN UNAPPROVED INDICATION |
202 |
0.0008 |
| 403 |
SENSITIVE SKIN |
6 |
0.0008 |
| 404 |
BLOOD MAGNESIUM DECREASED |
7 |
0.0008 |
| 405 |
HYPERVOLAEMIA |
4 |
0.0008 |
| 406 |
SCOLIOSIS |
5 |
0.0008 |
| 407 |
INTENTIONAL DOSE OMISSION |
23 |
0.0008 |
| 408 |
DEVICE USE ISSUE |
14 |
0.0008 |
| 409 |
BACK DISORDER |
13 |
0.0008 |
| 410 |
FLUID INTAKE REDUCED |
4 |
0.0008 |
| 411 |
VEIN DISORDER |
4 |
0.0008 |
| 412 |
EATING DISORDER |
17 |
0.0008 |
| 413 |
SPINAL OSTEOARTHRITIS |
7 |
0.0008 |
| 414 |
DERMATITIS ATOPIC |
42 |
0.0008 |
| 415 |
BLEPHAROSPASM |
5 |
0.0008 |
| 416 |
AUTOIMMUNE THYROIDITIS |
3 |
0.0008 |
| 417 |
EYE DISORDER |
26 |
0.0008 |
| 418 |
CORONARY ARTERIAL STENT INSERTION |
4 |
0.0008 |
| 419 |
DRY MOUTH |
64 |
0.0008 |
| 420 |
STAPHYLOCOCCAL INFECTION |
26 |
0.0008 |
| 421 |
NECK PAIN |
44 |
0.0008 |
| 422 |
PHOTOSENSITIVITY REACTION |
13 |
0.0008 |
| 423 |
ACCIDENTAL EXPOSURE TO PRODUCT |
81 |
0.0008 |
| 424 |
TOOTH ABSCESS |
8 |
0.0008 |
| 425 |
PRODUCT PREPARATION ERROR |
16 |
0.0008 |
| 426 |
ROTATOR CUFF SYNDROME |
10 |
0.0008 |
| 427 |
CONCUSSION |
6 |
0.0008 |
| 428 |
VARICOSE VEIN |
4 |
0.0008 |
| 429 |
CARDIAC FLUTTER |
5 |
0.0008 |
| 430 |
TOOTHACHE |
14 |
0.0008 |
| 431 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
5 |
0.0008 |
| 432 |
PLATELET COUNT INCREASED |
10 |
0.0008 |
| 433 |
PNEUMOTHORAX |
12 |
0.0008 |
| 434 |
CORONAVIRUS INFECTION |
5 |
0.0008 |
| 435 |
OEDEMA |
41 |
0.0008 |
| 436 |
NEEDLE ISSUE |
22 |
0.0008 |
| 437 |
ARTERIOSCLEROSIS CORONARY ARTERY |
5 |
0.0008 |
| 438 |
CHROMATURIA |
17 |
0.0008 |
| 439 |
SLEEP DISORDER |
53 |
0.0008 |
| 440 |
WRIST FRACTURE |
9 |
0.0008 |
| 441 |
IRRITABLE BOWEL SYNDROME |
16 |
0.0007 |
| 442 |
POOR QUALITY SLEEP |
16 |
0.0007 |
| 443 |
MYASTHENIA GRAVIS |
6 |
0.0007 |
| 444 |
BRONCHIECTASIS |
5 |
0.0007 |
| 445 |
MUSCLE TIGHTNESS |
12 |
0.0007 |
| 446 |
DYSPNOEA |
418 |
0.0007 |
| 447 |
ABDOMINAL DISTENSION |
77 |
0.0007 |
| 448 |
PRODUCT LABEL ISSUE |
5 |
0.0007 |
| 449 |
PNEUMONIA |
238 |
0.0007 |
| 450 |
SPINAL OPERATION |
9 |
0.0007 |
| 451 |
HYPOAESTHESIA ORAL |
11 |
0.0007 |
| 452 |
GENERALISED OEDEMA |
9 |
0.0007 |
| 453 |
HEART RATE ABNORMAL |
4 |
0.0007 |
| 454 |
EXTRASYSTOLES |
5 |
0.0007 |
| 455 |
RESTLESS LEGS SYNDROME |
13 |
0.0007 |
| 456 |
KNEE ARTHROPLASTY |
15 |
0.0007 |
| 457 |
SENSATION OF FOREIGN BODY |
6 |
0.0007 |
| 458 |
DRY SKIN |
95 |
0.0007 |
| 459 |
MUSCULOSKELETAL CHEST PAIN |
11 |
0.0007 |
| 460 |
HYPOXIA |
25 |
0.0007 |
| 461 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
37 |
0.0007 |
| 462 |
HEART RATE INCREASED |
70 |
0.0007 |
| 463 |
HAND FRACTURE |
5 |
0.0007 |
| 464 |
VITAMIN D DECREASED |
6 |
0.0007 |
| 465 |
SCAR |
12 |
0.0007 |
| 466 |
BRONCHOSPASM |
10 |
0.0007 |
| 467 |
BLOOD PRESSURE INCREASED |
107 |
0.0007 |
| 468 |
SPINAL FRACTURE |
14 |
0.0007 |
| 469 |
HEPATIC STEATOSIS |
13 |
0.0007 |
| 470 |
POOR QUALITY DEVICE USED |
7 |
0.0007 |
| 471 |
HYPERSOMNIA |
20 |
0.0007 |
| 472 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 473 |
PARAESTHESIA ORAL |
10 |
0.0007 |
| 474 |
VISION BLURRED |
95 |
0.0007 |
| 475 |
INJECTION SITE RASH |
21 |
0.0007 |
| 476 |
HEADACHE |
426 |
0.0007 |
| 477 |
DECREASED INTEREST |
4 |
0.0007 |
| 478 |
PSYCHIATRIC SYMPTOM |
5 |
0.0007 |
| 479 |
GLUCOSE TOLERANCE IMPAIRED |
4 |
0.0007 |
| 480 |
CATARACT OPERATION |
4 |
0.0007 |
| 481 |
CHILLS |
79 |
0.0007 |
| 482 |
LUNG DISORDER |
33 |
0.0007 |
| 483 |
PULMONARY HYPERTENSION |
14 |
0.0007 |
| 484 |
MALIGNANT MELANOMA |
9 |
0.0007 |
| 485 |
CARDIAC PACEMAKER INSERTION |
4 |
0.0007 |
| 486 |
PETECHIAE |
7 |
0.0007 |
| 487 |
PAIN IN JAW |
19 |
0.0007 |
| 488 |
FULL BLOOD COUNT ABNORMAL |
7 |
0.0007 |
| 489 |
GAIT INABILITY |
22 |
0.0007 |
| 490 |
NEURALGIA |
16 |
0.0007 |
| 491 |
JOINT INJURY |
14 |
0.0007 |
| 492 |
BOWEL MOVEMENT IRREGULARITY |
5 |
0.0007 |
| 493 |
UPPER LIMB FRACTURE |
13 |
0.0007 |
| 494 |
PIGMENTATION DISORDER |
4 |
0.0006 |
| 495 |
GASTROOESOPHAGEAL REFLUX DISEASE |
52 |
0.0006 |
| 496 |
PERIPHERAL SWELLING |
99 |
0.0006 |
| 497 |
ORTHOSTATIC HYPOTENSION |
11 |
0.0006 |
| 498 |
FEELING JITTERY |
12 |
0.0006 |
| 499 |
FLUID RETENTION |
32 |
0.0006 |
| 500 |
BACK PAIN |
146 |
0.0006 |
| 501 |
OBESITY |
10 |
0.0006 |
| 502 |
SUPRAVENTRICULAR TACHYCARDIA |
6 |
0.0006 |
| 503 |
HERPES ZOSTER |
36 |
0.0006 |
| 504 |
INJECTION SITE PAIN |
191 |
0.0006 |
| 505 |
FALL |
207 |
0.0006 |
| 506 |
HAEMOGLOBIN ABNORMAL |
4 |
0.0006 |
| 507 |
HYPERCHOLESTEROLAEMIA |
6 |
0.0006 |
| 508 |
FATIGUE |
483 |
0.0006 |
| 509 |
COMPLICATION ASSOCIATED WITH DEVICE |
9 |
0.0006 |
| 510 |
SKIN LESION |
17 |
0.0006 |
| 511 |
PRODUCT USE ISSUE |
116 |
0.0006 |
| 512 |
APATHY |
9 |
0.0006 |
| 513 |
PARKINSONISM |
6 |
0.0006 |
| 514 |
DECUBITUS ULCER |
5 |
0.0006 |
| 515 |
POLYP |
4 |
0.0006 |
| 516 |
NEPHROLITHIASIS |
28 |
0.0006 |
| 517 |
VITREOUS FLOATERS |
6 |
0.0006 |
| 518 |
PRODUCT PREPARATION ISSUE |
4 |
0.0006 |
| 519 |
HOSPICE CARE |
6 |
0.0006 |
| 520 |
DYSGRAPHIA |
4 |
0.0006 |
| 521 |
WALKING AID USER |
4 |
0.0006 |
| 522 |
SKIN DISORDER |
20 |
0.0006 |
| 523 |
ROAD TRAFFIC ACCIDENT |
25 |
0.0006 |
| 524 |
INJECTION SITE PRURITUS |
40 |
0.0006 |
| 525 |
FULL BLOOD COUNT DECREASED |
12 |
0.0006 |
| 526 |
PRODUCT PHYSICAL ISSUE |
12 |
0.0006 |
| 527 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
15 |
0.0006 |
| 528 |
PRODUCT ADMINISTRATION ERROR |
12 |
0.0006 |
| 529 |
FEEDING DISORDER |
12 |
0.0006 |
| 530 |
ULCER HAEMORRHAGE |
4 |
0.0006 |
| 531 |
INJECTION SITE BRUISING |
47 |
0.0006 |
| 532 |
CATARACT |
35 |
0.0006 |
| 533 |
ABNORMAL LOSS OF WEIGHT |
4 |
0.0006 |
| 534 |
FACIAL PARALYSIS |
5 |
0.0006 |
| 535 |
GINGIVAL BLEEDING |
8 |
0.0006 |
| 536 |
DEVICE RELATED INFECTION |
9 |
0.0006 |
| 537 |
PRURITUS |
224 |
0.0006 |
| 538 |
SKIN EXFOLIATION |
49 |
0.0006 |
| 539 |
BONE PAIN |
34 |
0.0006 |
| 540 |
LYMPHOEDEMA |
4 |
0.0006 |
| 541 |
BASAL CELL CARCINOMA |
9 |
0.0006 |
| 542 |
PROCEDURAL PAIN |
16 |
0.0006 |
| 543 |
FIBROMYALGIA |
14 |
0.0006 |
| 544 |
DEAFNESS |
15 |
0.0006 |
| 545 |
RASH MACULAR |
20 |
0.0006 |
| 546 |
INJECTION SITE URTICARIA |
14 |
0.0006 |
| 547 |
GASTROINTESTINAL DISORDER |
51 |
0.0006 |
| 548 |
HEAD INJURY |
18 |
0.0006 |
| 549 |
DEVICE OCCLUSION |
8 |
0.0006 |
| 550 |
DIZZINESS |
282 |
0.0006 |
| 551 |
CHOKING |
11 |
0.0006 |
| 552 |
TRANSIENT ISCHAEMIC ATTACK |
19 |
0.0006 |
| 553 |
SURGERY |
33 |
0.0006 |
| 554 |
PERICARDIAL EFFUSION |
13 |
0.0006 |
| 555 |
THIRST |
10 |
0.0006 |
| 556 |
RED BLOOD CELL COUNT DECREASED |
16 |
0.0006 |
| 557 |
ARTHRITIS |
44 |
0.0006 |
| 558 |
DERMATITIS ALLERGIC |
7 |
0.0006 |
| 559 |
THERAPY NON-RESPONDER |
25 |
0.0006 |
| 560 |
CELLULITIS |
28 |
0.0006 |
| 561 |
ARTHRALGIA |
231 |
0.0006 |
| 562 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
12 |
0.0006 |
| 563 |
LOWER RESPIRATORY TRACT INFECTION |
25 |
0.0005 |
| 564 |
LIQUID PRODUCT PHYSICAL ISSUE |
4 |
0.0005 |
| 565 |
EXOSTOSIS |
5 |
0.0005 |
| 566 |
FLATULENCE |
31 |
0.0005 |
| 567 |
THERAPY INTERRUPTED |
39 |
0.0005 |
| 568 |
INJECTION SITE NODULE |
6 |
0.0005 |
| 569 |
RASH ERYTHEMATOUS |
26 |
0.0005 |
| 570 |
DENTAL CARIES |
6 |
0.0005 |
| 571 |
FEELING DRUNK |
4 |
0.0005 |
| 572 |
WEIGHT DECREASED |
150 |
0.0005 |
| 573 |
NERVOUSNESS |
28 |
0.0005 |
| 574 |
APPENDICITIS |
5 |
0.0005 |
| 575 |
SWELLING |
50 |
0.0005 |
| 576 |
HYPOTHYROIDISM |
17 |
0.0005 |
| 577 |
INJECTION SITE ERYTHEMA |
66 |
0.0005 |
| 578 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 579 |
REBOUND EFFECT |
6 |
0.0005 |
| 580 |
MUSCLE SPASMS |
97 |
0.0005 |
| 581 |
PRODUCT AVAILABILITY ISSUE |
12 |
0.0005 |
| 582 |
SCAB |
6 |
0.0005 |
| 583 |
DERMATITIS |
11 |
0.0005 |
| 584 |
SWELLING FACE |
34 |
0.0005 |
| 585 |
PULMONARY FIBROSIS |
10 |
0.0005 |
| 586 |
OSTEOARTHRITIS |
22 |
0.0005 |
| 587 |
HERNIA |
10 |
0.0005 |
| 588 |
ANKLE FRACTURE |
8 |
0.0005 |
| 589 |
TENDONITIS |
8 |
0.0005 |
| 590 |
SOMNOLENCE |
104 |
0.0005 |
| 591 |
DEVICE INFORMATION OUTPUT ISSUE |
4 |
0.0005 |
| 592 |
PELVIC FRACTURE |
4 |
0.0005 |
| 593 |
WEIGHT INCREASED |
115 |
0.0005 |
| 594 |
VITAMIN D DEFICIENCY |
5 |
0.0005 |
| 595 |
ABDOMINAL DISCOMFORT |
86 |
0.0005 |
| 596 |
SWOLLEN TONGUE |
16 |
0.0005 |
| 597 |
BLOOD PRESSURE DECREASED |
34 |
0.0005 |
| 598 |
PAIN |
314 |
0.0005 |
| 599 |
FEELING ABNORMAL |
122 |
0.0005 |
| 600 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
7 |
0.0005 |
| 601 |
DRUG SCREEN POSITIVE |
4 |
0.0005 |
| 602 |
BACTERAEMIA |
6 |
0.0005 |
| 603 |
HAEMATOCRIT DECREASED |
10 |
0.0005 |
| 604 |
HUNGER |
7 |
0.0005 |
| 605 |
HYPERLIPIDAEMIA |
6 |
0.0005 |
| 606 |
POLYNEUROPATHY |
6 |
0.0005 |
| 607 |
MASS |
7 |
0.0005 |
| 608 |
BLOOD PRESSURE FLUCTUATION |
12 |
0.0005 |
| 609 |
BLOOD DISORDER |
4 |
0.0005 |
| 610 |
NIGHT SWEATS |
16 |
0.0005 |
| 611 |
CONSTIPATION |
107 |
0.0005 |
| 612 |
GAIT DISTURBANCE |
93 |
0.0005 |
| 613 |
BALANCE DISORDER |
42 |
0.0005 |
| 614 |
HEART RATE DECREASED |
17 |
0.0005 |
| 615 |
CONDITION AGGRAVATED |
147 |
0.0005 |
| 616 |
PULMONARY ARTERIAL HYPERTENSION |
7 |
0.0005 |
| 617 |
LYMPHADENOPATHY |
17 |
0.0005 |
| 618 |
RASH PRURITIC |
26 |
0.0005 |
| 619 |
POLLAKIURIA |
20 |
0.0005 |
| 620 |
INTENTIONAL PRODUCT USE ISSUE |
42 |
0.0005 |
| 621 |
HEPATIC CIRRHOSIS |
9 |
0.0005 |
| 622 |
PALPITATIONS |
56 |
0.0005 |
| 623 |
URTICARIA |
80 |
0.0005 |
| 624 |
VERTIGO |
29 |
0.0005 |
| 625 |
PAIN IN EXTREMITY |
140 |
0.0005 |
| 626 |
MUSCLE ATROPHY |
6 |
0.0005 |
| 627 |
INSOMNIA |
125 |
0.0005 |
| 628 |
WHITE BLOOD CELL COUNT INCREASED |
18 |
0.0005 |
| 629 |
DIVERTICULITIS |
13 |
0.0005 |
| 630 |
EXTRA DOSE ADMINISTERED |
19 |
0.0005 |
| 631 |
MYDRIASIS |
6 |
0.0005 |
| 632 |
DRUG INEFFECTIVE |
615 |
0.0005 |
| 633 |
HIP FRACTURE |
15 |
0.0005 |
| 634 |
HAEMOPTYSIS |
13 |
0.0005 |
| 635 |
CARDIAC OPERATION |
4 |
0.0005 |
| 636 |
HOT FLUSH |
35 |
0.0005 |
| 637 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
33 |
0.0005 |
| 638 |
CONTRAINDICATED PRODUCT ADMINISTERED |
14 |
0.0005 |
| 639 |
FLUSHING |
47 |
0.0005 |
| 640 |
OSTEOPOROSIS |
19 |
0.0005 |
| 641 |
ABDOMINAL PAIN UPPER |
95 |
0.0005 |
| 642 |
RASH |
201 |
0.0005 |
| 643 |
SPEECH DISORDER |
24 |
0.0005 |
| 644 |
DEHYDRATION |
61 |
0.0005 |
| 645 |
BURNING SENSATION |
32 |
0.0005 |
| 646 |
ANKYLOSING SPONDYLITIS |
6 |
0.0005 |
| 647 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 648 |
APPETITE DISORDER |
3 |
0.0005 |
| 649 |
PURPURA |
4 |
0.0005 |
| 650 |
LETHARGY |
26 |
0.0005 |
| 651 |
ATRIAL FIBRILLATION |
44 |
0.0005 |
| 652 |
PRODUCT SUBSTITUTION ISSUE |
26 |
0.0005 |
| 653 |
NERVE INJURY |
5 |
0.0004 |
| 654 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 655 |
MYALGIA |
76 |
0.0004 |
| 656 |
ORAL PAIN |
10 |
0.0004 |
| 657 |
HAEMARTHROSIS |
4 |
0.0004 |
| 658 |
LIP DRY |
4 |
0.0004 |
| 659 |
PNEUMONIA ASPIRATION |
11 |
0.0004 |
| 660 |
MALAISE |
193 |
0.0004 |
| 661 |
ULCER |
7 |
0.0004 |
| 662 |
INTERNAL HAEMORRHAGE |
5 |
0.0004 |
| 663 |
RIB FRACTURE |
9 |
0.0004 |
| 664 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
24 |
0.0004 |
| 665 |
DIARRHOEA |
282 |
0.0004 |
| 666 |
ASTHENIA |
163 |
0.0004 |
| 667 |
ORAL DISCOMFORT |
6 |
0.0004 |
| 668 |
MEMORY IMPAIRMENT |
59 |
0.0004 |
| 669 |
NEPHROPATHY |
4 |
0.0004 |
| 670 |
NAUSEA |
339 |
0.0004 |
| 671 |
HYPOAESTHESIA |
64 |
0.0004 |
| 672 |
INFLAMMATION |
22 |
0.0004 |
| 673 |
INFLUENZA LIKE ILLNESS |
35 |
0.0004 |
| 674 |
THERAPEUTIC RESPONSE UNEXPECTED |
19 |
0.0004 |
| 675 |
THROMBOSIS |
34 |
0.0004 |
| 676 |
LIMB DISCOMFORT |
13 |
0.0004 |
| 677 |
VISUAL IMPAIRMENT |
52 |
0.0004 |
| 678 |
RECALLED PRODUCT ADMINISTERED |
4 |
0.0004 |
| 679 |
HYPOACUSIS |
18 |
0.0004 |
| 680 |
POST PROCEDURAL COMPLICATION |
8 |
0.0004 |
| 681 |
LOWER LIMB FRACTURE |
8 |
0.0004 |
| 682 |
ANAPHYLACTIC REACTION |
23 |
0.0004 |
| 683 |
DEPRESSED MOOD |
22 |
0.0004 |
| 684 |
GLAUCOMA |
8 |
0.0004 |
| 685 |
TINNITUS |
19 |
0.0004 |
| 686 |
ERUCTATION |
8 |
0.0004 |
| 687 |
PRESYNCOPE |
10 |
0.0004 |
| 688 |
DYSSTASIA |
12 |
0.0004 |
| 689 |
DISTURBANCE IN ATTENTION |
22 |
0.0004 |
| 690 |
COELIAC DISEASE |
4 |
0.0004 |
| 691 |
DECREASED IMMUNE RESPONSIVENESS |
4 |
0.0004 |
| 692 |
THERAPY CHANGE |
4 |
0.0004 |
| 693 |
BODY TEMPERATURE DECREASED |
4 |
0.0004 |
| 694 |
CARDIAC DISORDER |
38 |
0.0004 |
| 695 |
URINARY INCONTINENCE |
12 |
0.0004 |
| 696 |
BLADDER DISORDER |
4 |
0.0004 |
| 697 |
TOOTH EXTRACTION |
5 |
0.0004 |
| 698 |
HYPERTENSION |
85 |
0.0004 |
| 699 |
DECREASED APPETITE |
93 |
0.0004 |
| 700 |
DYSPHAGIA |
38 |
0.0004 |
| 701 |
ERYTHEMA |
82 |
0.0004 |
| 702 |
PYREXIA |
138 |
0.0004 |
| 703 |
HYPOTENSION |
80 |
0.0004 |
| 704 |
DEPRESSION |
90 |
0.0004 |
| 705 |
DRUG ERUPTION |
7 |
0.0004 |
| 706 |
DYSKINESIA |
16 |
0.0004 |
| 707 |
LIP SWELLING |
13 |
0.0004 |
| 708 |
ERECTILE DYSFUNCTION |
10 |
0.0004 |
| 709 |
TEMPERATURE INTOLERANCE |
4 |
0.0004 |
| 710 |
LEUKOCYTOSIS |
7 |
0.0004 |
| 711 |
OSTEOMYELITIS |
7 |
0.0004 |
| 712 |
INJECTION SITE INDURATION |
5 |
0.0004 |
| 713 |
CHEST PAIN |
71 |
0.0004 |
| 714 |
POOR QUALITY PRODUCT ADMINISTERED |
4 |
0.0004 |
| 715 |
THERAPEUTIC RESPONSE DECREASED |
23 |
0.0004 |
| 716 |
SCRATCH |
4 |
0.0004 |
| 717 |
JOINT DISLOCATION |
4 |
0.0004 |
| 718 |
OEDEMA PERIPHERAL |
46 |
0.0004 |
| 719 |
DISCOMFORT |
23 |
0.0004 |
| 720 |
ANXIETY |
107 |
0.0004 |
| 721 |
QUALITY OF LIFE DECREASED |
5 |
0.0004 |
| 722 |
FREQUENT BOWEL MOVEMENTS |
10 |
0.0004 |
| 723 |
SKIN DISCOLOURATION |
17 |
0.0004 |
| 724 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 725 |
FAECES DISCOLOURED |
8 |
0.0004 |
| 726 |
PRODUCT PRESCRIBING ISSUE |
8 |
0.0004 |
| 727 |
PULMONARY THROMBOSIS |
4 |
0.0004 |
| 728 |
AKATHISIA |
5 |
0.0004 |
| 729 |
INCREASED APPETITE |
7 |
0.0004 |
| 730 |
OESOPHAGITIS |
4 |
0.0004 |
| 731 |
BLOOD GLUCOSE FLUCTUATION |
4 |
0.0004 |
| 732 |
RENAL DISORDER |
17 |
0.0004 |
| 733 |
BLOOD CHOLESTEROL INCREASED |
17 |
0.0004 |
| 734 |
PERIPHERAL COLDNESS |
5 |
0.0004 |
| 735 |
ACUTE RESPIRATORY FAILURE |
7 |
0.0004 |
| 736 |
GASTROINTESTINAL PAIN |
4 |
0.0004 |
| 737 |
TOOTH FRACTURE |
4 |
0.0004 |
| 738 |
RESPIRATORY DISTRESS |
10 |
0.0004 |
| 739 |
PSYCHOMOTOR HYPERACTIVITY |
6 |
0.0004 |
| 740 |
FEELING COLD |
10 |
0.0004 |
| 741 |
CARPAL TUNNEL SYNDROME |
5 |
0.0004 |
| 742 |
BLOOD TEST ABNORMAL |
5 |
0.0004 |
| 743 |
BLOOD CALCIUM DECREASED |
4 |
0.0004 |
| 744 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
72 |
0.0004 |
| 745 |
HEART RATE IRREGULAR |
8 |
0.0004 |
| 746 |
BLOOD GLUCOSE DECREASED |
17 |
0.0004 |
| 747 |
DISABILITY |
7 |
0.0004 |
| 748 |
DYSURIA |
13 |
0.0004 |
| 749 |
CHOLECYSTECTOMY |
4 |
0.0003 |
| 750 |
TACHYCARDIA |
31 |
0.0003 |
| 751 |
NEOPLASM |
4 |
0.0003 |
| 752 |
GASTRIC HAEMORRHAGE |
4 |
0.0003 |
| 753 |
NEUROPATHY PERIPHERAL |
33 |
0.0003 |
| 754 |
VOMITING |
162 |
0.0003 |
| 755 |
BODY TEMPERATURE INCREASED |
7 |
0.0003 |
| 756 |
JOINT STIFFNESS |
9 |
0.0003 |
| 757 |
INCORRECT DOSE ADMINISTERED |
78 |
0.0003 |
| 758 |
SPLENOMEGALY |
4 |
0.0003 |
| 759 |
INJECTION SITE WARMTH |
7 |
0.0003 |
| 760 |
GALLBLADDER DISORDER |
6 |
0.0003 |
| 761 |
CHOLELITHIASIS |
11 |
0.0003 |
| 762 |
IMMUNODEFICIENCY |
5 |
0.0003 |
| 763 |
ACCIDENT |
4 |
0.0003 |
| 764 |
FEAR |
9 |
0.0003 |
| 765 |
HYPERHIDROSIS |
43 |
0.0003 |
| 766 |
ANAL INCONTINENCE |
3 |
0.0003 |
| 767 |
JOINT SWELLING |
40 |
0.0003 |
| 768 |
APHASIA |
10 |
0.0003 |
| 769 |
MUSCULOSKELETAL STIFFNESS |
29 |
0.0003 |
| 770 |
PNEUMONITIS |
9 |
0.0003 |
| 771 |
NOCTURIA |
4 |
0.0003 |
| 772 |
TYPE 2 DIABETES MELLITUS |
11 |
0.0003 |
| 773 |
LIVER FUNCTION TEST INCREASED |
7 |
0.0003 |
| 774 |
ABNORMAL DREAMS |
9 |
0.0003 |
| 775 |
SKIN CANCER |
7 |
0.0003 |
| 776 |
BLOOD GLUCOSE ABNORMAL |
6 |
0.0003 |
| 777 |
INJECTION SITE MASS |
12 |
0.0003 |
| 778 |
PRODUCT QUALITY ISSUE |
44 |
0.0003 |
| 779 |
LYMPHOMA |
5 |
0.0003 |
| 780 |
MENTAL DISORDER |
14 |
0.0003 |
| 781 |
DRUG INTOLERANCE |
31 |
0.0003 |
| 782 |
CLOSTRIDIUM DIFFICILE INFECTION |
7 |
0.0003 |
| 783 |
BLISTER |
18 |
0.0003 |
| 784 |
TREMOR |
53 |
0.0003 |
| 785 |
CYANOSIS |
5 |
0.0003 |
| 786 |
PARAESTHESIA |
50 |
0.0003 |
| 787 |
MUSCULAR WEAKNESS |
36 |
0.0003 |
| 788 |
BLOOD URINE PRESENT |
6 |
0.0003 |
| 789 |
IRRITABILITY |
19 |
0.0003 |
| 790 |
GASTRIC ULCER |
6 |
0.0003 |
| 791 |
MUSCULOSKELETAL DISORDER |
6 |
0.0003 |
| 792 |
DIABETES MELLITUS |
24 |
0.0003 |
| 793 |
TOOTH DISORDER |
7 |
0.0003 |
| 794 |
HALLUCINATION, AUDITORY |
5 |
0.0003 |
| 795 |
INJECTION SITE IRRITATION |
4 |
0.0003 |
| 796 |
INTRAOCULAR PRESSURE INCREASED |
4 |
0.0003 |
| 797 |
GLOSSODYNIA |
7 |
0.0003 |
| 798 |
CHOLESTASIS |
6 |
0.0003 |
| 799 |
SENSORY DISTURBANCE |
5 |
0.0003 |
| 800 |
LIVER FUNCTION TEST ABNORMAL |
9 |
0.0003 |
| 801 |
DIPLOPIA |
8 |
0.0003 |
| 802 |
ARTHROPATHY |
17 |
0.0003 |
| 803 |
SEDATION |
8 |
0.0003 |
| 804 |
DYSPEPSIA |
30 |
0.0003 |
| 805 |
MULTIPLE FRACTURES |
5 |
0.0003 |
| 806 |
BEDRIDDEN |
4 |
0.0003 |
| 807 |
GASTRITIS |
8 |
0.0003 |
| 808 |
ACCIDENTAL OVERDOSE |
11 |
0.0003 |
| 809 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
14 |
0.0003 |
| 810 |
RHEUMATOID ARTHRITIS |
34 |
0.0003 |
| 811 |
DEVICE DISLOCATION |
13 |
0.0003 |
| 812 |
DISEASE RECURRENCE |
14 |
0.0003 |
| 813 |
MULTIPLE SCLEROSIS |
14 |
0.0003 |
| 814 |
THERAPY CESSATION |
15 |
0.0003 |
| 815 |
INTESTINAL OBSTRUCTION |
11 |
0.0003 |
| 816 |
PULMONARY OEDEMA |
13 |
0.0003 |
| 817 |
MENTAL STATUS CHANGES |
8 |
0.0003 |
| 818 |
WOUND |
8 |
0.0003 |
| 819 |
SEIZURE |
33 |
0.0003 |
| 820 |
COLD SWEAT |
5 |
0.0003 |
| 821 |
BLOOD TRIGLYCERIDES INCREASED |
5 |
0.0003 |
| 822 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
8 |
0.0003 |
| 823 |
FEELING HOT |
17 |
0.0003 |
| 824 |
BACK INJURY |
3 |
0.0003 |
| 825 |
HYPOKINESIA |
4 |
0.0003 |
| 826 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 827 |
CRYING |
10 |
0.0003 |
| 828 |
TREATMENT NONCOMPLIANCE |
15 |
0.0003 |
| 829 |
GASTROENTERITIS |
4 |
0.0003 |
| 830 |
ASPIRATION |
3 |
0.0003 |
| 831 |
LABORATORY TEST ABNORMAL |
8 |
0.0003 |
| 832 |
EXPIRED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 833 |
URINARY RETENTION |
9 |
0.0003 |
| 834 |
THINKING ABNORMAL |
5 |
0.0003 |
| 835 |
MOBILITY DECREASED |
19 |
0.0003 |
| 836 |
ECONOMIC PROBLEM |
4 |
0.0003 |
| 837 |
STOMATITIS |
16 |
0.0003 |
| 838 |
COLITIS |
10 |
0.0003 |
| 839 |
PLEURAL EFFUSION |
16 |
0.0003 |
| 840 |
SKIN IRRITATION |
12 |
0.0003 |
| 841 |
EPILEPSY |
8 |
0.0003 |
| 842 |
INJECTION SITE REACTION |
18 |
0.0003 |
| 843 |
NIGHTMARE |
9 |
0.0003 |
| 844 |
BLOOD BILIRUBIN INCREASED |
7 |
0.0003 |
| 845 |
PALLOR |
7 |
0.0003 |
| 846 |
INTENTIONAL PRODUCT MISUSE |
22 |
0.0003 |
| 847 |
UNEVALUABLE EVENT |
19 |
0.0003 |
| 848 |
SEPSIS |
28 |
0.0003 |
| 849 |
DEMENTIA |
7 |
0.0003 |
| 850 |
LOSS OF CONSCIOUSNESS |
32 |
0.0002 |
| 851 |
MULTIPLE SCLEROSIS RELAPSE |
17 |
0.0002 |
| 852 |
HYPOGLYCAEMIA |
12 |
0.0002 |
| 853 |
HOSPITALISATION |
38 |
0.0002 |
| 854 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 855 |
ILL-DEFINED DISORDER |
15 |
0.0002 |
| 856 |
RESTLESSNESS |
9 |
0.0002 |
| 857 |
INJURY ASSOCIATED WITH DEVICE |
5 |
0.0002 |
| 858 |
MANIA |
4 |
0.0002 |
| 859 |
WHITE BLOOD CELL COUNT DECREASED |
26 |
0.0002 |
| 860 |
NEOPLASM MALIGNANT |
16 |
0.0002 |
| 861 |
DYSARTHRIA |
9 |
0.0002 |
| 862 |
COGNITIVE DISORDER |
11 |
0.0002 |
| 863 |
HAEMATOMA |
6 |
0.0002 |
| 864 |
SYNCOPE |
23 |
0.0002 |
| 865 |
HAEMORRHAGE |
24 |
0.0002 |
| 866 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
6 |
0.0002 |
| 867 |
DISEASE PROGRESSION |
27 |
0.0002 |
| 868 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
9 |
0.0002 |
| 869 |
HAEMOGLOBIN DECREASED |
23 |
0.0002 |
| 870 |
CHRONIC KIDNEY DISEASE |
17 |
0.0002 |
| 871 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
10 |
0.0002 |
| 872 |
JAUNDICE |
6 |
0.0002 |
| 873 |
PAIN OF SKIN |
6 |
0.0002 |
| 874 |
ANAEMIA |
42 |
0.0002 |
| 875 |
MOOD ALTERED |
6 |
0.0002 |
| 876 |
BONE DISORDER |
4 |
0.0002 |
| 877 |
PANIC ATTACK |
8 |
0.0002 |
| 878 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 879 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
4 |
0.0002 |
| 880 |
HAEMATOCHEZIA |
12 |
0.0002 |
| 881 |
SHOCK |
5 |
0.0002 |
| 882 |
MUSCLE TWITCHING |
5 |
0.0002 |
| 883 |
HYPOKALAEMIA |
10 |
0.0002 |
| 884 |
PLATELET COUNT DECREASED |
23 |
0.0002 |
| 885 |
TUBULOINTERSTITIAL NEPHRITIS |
4 |
0.0002 |
| 886 |
HALLUCINATION |
16 |
0.0002 |
| 887 |
FRACTURE |
4 |
0.0002 |
| 888 |
OFF LABEL USE |
185 |
0.0002 |
| 889 |
BLOOD GLUCOSE INCREASED |
39 |
0.0002 |
| 890 |
ABDOMINAL PAIN |
48 |
0.0002 |
| 891 |
UNDERDOSE |
15 |
0.0002 |
| 892 |
HAEMORRHOIDS |
4 |
0.0002 |
| 893 |
ALOPECIA |
40 |
0.0002 |
| 894 |
DEEP VEIN THROMBOSIS |
13 |
0.0002 |
| 895 |
PREGNANCY |
4 |
0.0002 |
| 896 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
7 |
0.0002 |
| 897 |
DRUG ADMINISTRATION ERROR |
6 |
0.0002 |
| 898 |
PRODUCT STORAGE ERROR |
17 |
0.0002 |
| 899 |
SKIN ULCER |
5 |
0.0002 |
| 900 |
TOOTH LOSS |
4 |
0.0002 |
| 901 |
CONFUSIONAL STATE |
31 |
0.0002 |
| 902 |
ANHEDONIA |
5 |
0.0002 |
| 903 |
EMOTIONAL DISTRESS |
23 |
0.0002 |
| 904 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 905 |
RENAL FAILURE |
25 |
0.0002 |
| 906 |
ASPARTATE AMINOTRANSFERASE INCREASED |
10 |
0.0002 |
| 907 |
MOOD SWINGS |
6 |
0.0002 |
| 908 |
ABSCESS |
3 |
0.0002 |
| 909 |
INJECTION SITE HAEMORRHAGE |
15 |
0.0002 |
| 910 |
BREAST CANCER FEMALE |
5 |
0.0002 |
| 911 |
AMNESIA |
12 |
0.0002 |
| 912 |
IMPAIRED HEALING |
6 |
0.0002 |
| 913 |
ANGIOEDEMA |
8 |
0.0002 |
| 914 |
LIVER DISORDER |
8 |
0.0002 |
| 915 |
ALANINE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 916 |
PANCREATITIS ACUTE |
4 |
0.0002 |
| 917 |
ANGER |
6 |
0.0002 |
| 918 |
AGITATION |
13 |
0.0002 |
| 919 |
EXPOSURE DURING PREGNANCY |
11 |
0.0002 |
| 920 |
DISORIENTATION |
7 |
0.0002 |
| 921 |
APPLICATION SITE PRURITUS |
4 |
0.0002 |
| 922 |
ABORTION SPONTANEOUS |
7 |
0.0002 |
| 923 |
PULMONARY EMBOLISM |
16 |
0.0002 |
| 924 |
ADVERSE DRUG REACTION |
15 |
0.0002 |
| 925 |
DEVICE DIFFICULT TO USE |
11 |
0.0002 |
| 926 |
MENTAL IMPAIRMENT |
4 |
0.0002 |
| 927 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 928 |
CARDIAC FAILURE CONGESTIVE |
13 |
0.0002 |
| 929 |
HEPATIC ENZYME INCREASED |
11 |
0.0002 |
| 930 |
PSORIASIS |
21 |
0.0002 |
| 931 |
CEREBROVASCULAR ACCIDENT |
27 |
0.0002 |
| 932 |
ABDOMINAL PAIN LOWER |
4 |
0.0002 |
| 933 |
COLITIS ULCERATIVE |
7 |
0.0002 |
| 934 |
INJURY |
11 |
0.0002 |
| 935 |
GASTROINTESTINAL HAEMORRHAGE |
13 |
0.0002 |
| 936 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 937 |
APPLICATION SITE ERYTHEMA |
4 |
0.0002 |
| 938 |
ADVERSE EVENT |
14 |
0.0002 |
| 939 |
CARDIAC FAILURE |
12 |
0.0001 |
| 940 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 941 |
BLINDNESS |
6 |
0.0001 |
| 942 |
NEUTROPHIL COUNT DECREASED |
6 |
0.0001 |
| 943 |
ACNE |
11 |
0.0001 |
| 944 |
ACUTE KIDNEY INJURY |
22 |
0.0001 |
| 945 |
PANCYTOPENIA |
8 |
0.0001 |
| 946 |
WITHDRAWAL SYNDROME |
6 |
0.0001 |
| 947 |
INCORRECT DRUG ADMINISTRATION DURATION |
4 |
0.0001 |
| 948 |
ANGINA PECTORIS |
4 |
0.0001 |
| 949 |
VAGINAL HAEMORRHAGE |
6 |
0.0001 |
| 950 |
DRUG EFFECT INCOMPLETE |
5 |
0.0001 |
| 951 |
RENAL INJURY |
4 |
0.0001 |
| 952 |
MATERNAL EXPOSURE DURING PREGNANCY |
12 |
0.0001 |
| 953 |
PANCREATITIS |
7 |
0.0001 |
| 954 |
BRADYCARDIA |
7 |
0.0001 |
| 955 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 956 |
GENERAL PHYSICAL HEALTH DETERIORATION |
15 |
0.0001 |
| 957 |
ARRHYTHMIA |
6 |
0.0001 |
| 958 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
9 |
0.0001 |
| 959 |
MOVEMENT DISORDER |
4 |
0.0001 |
| 960 |
LUNG NEOPLASM MALIGNANT |
5 |
0.0001 |
| 961 |
AGGRESSION |
6 |
0.0001 |
| 962 |
HAEMATURIA |
4 |
0.0001 |
| 963 |
DEVICE USE ERROR |
4 |
0.0001 |
| 964 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 965 |
PRODUCT ADHESION ISSUE |
4 |
0.0001 |
| 966 |
CEREBRAL HAEMORRHAGE |
4 |
0.0001 |
| 967 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 968 |
RESPIRATORY FAILURE |
8 |
0.0001 |
| 969 |
BREAST CANCER |
10 |
0.0001 |
| 970 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 971 |
RENAL IMPAIRMENT |
9 |
0.0001 |
| 972 |
HYPONATRAEMIA |
6 |
0.0001 |
| 973 |
DEATH |
90 |
0.0001 |
| 974 |
MYOCARDIAL INFARCTION |
18 |
0.0001 |
| 975 |
ASCITES |
3 |
0.0001 |
| 976 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 977 |
CARDIAC ARREST |
8 |
0.0001 |
| 978 |
DRUG INTERACTION |
14 |
0.0001 |
| 979 |
DRUG DOSE OMISSION |
14 |
0.0001 |
| 980 |
COMA |
4 |
0.0001 |
| 981 |
INTERSTITIAL LUNG DISEASE |
4 |
0.0001 |
| 982 |
MUSCULOSKELETAL PAIN |
4 |
0.0001 |
| 983 |
MEDICATION ERROR |
4 |
0.0001 |
| 984 |
DRUG DEPENDENCE |
10 |
0.0001 |
| 985 |
PRODUCT DOSE OMISSION |
4 |
0.0001 |
| 986 |
DRUG DOSE OMISSION BY DEVICE |
4 |
0.0001 |
| 987 |
NEUTROPENIA |
6 |
0.0000 |
| 988 |
OVERDOSE |
9 |
0.0000 |
| 989 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 990 |
THROMBOCYTOPENIA |
4 |
0.0000 |